Elevra Lithium Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated October 29, 2025, reports on an announcement made on October 28, 2025, by Elevra Lithium Ltd (ASX: ELV). The filing details an application for quotation of new securities issued to satisfy outstanding underwriting fees related to a conditional institutional placement previously announced in November 2024 and approved by shareholders in July 2025.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, or margin data. It focuses exclusively on capital structure changes resulting from a non-cash issuance.
- Securities Issued: 287,500 Ordinary Fully Paid Shares.
- Consideration Type: Non-cash (satisfaction of underwriting fees owed to Canaccord Genuity).
- Implied Value per Security: AUD 4.80.
- Total Issued Capital (Post-Issue): 168,746,341 Ordinary Shares.
- Unquoted Securities: Includes 1,771,386 Performance Rights and various Options totaling approximately 17.6 million units.
Material Changes
The primary material change is the increase in issued share capital by 287,500 shares. This issuance was executed to settle the remaining underwriting fees for the institutional placement. The filing confirms that no further issues are required to complete the transaction referenced in the previous Appendix 3B announcement dated October 24, 2025.
Outlook, Risks, and Management Commentary
Management commentary is limited to the administrative details of the share issuance. The filing notes that the shares were issued to Canaccord Genuity. No specific forward-looking guidance, risk factors, or contingencies regarding operational performance or market conditions are disclosed in this specific document.
Investor Verification Checklist
- Verify the total number of shares on issue (168,746,341) against the company's latest quarterly or annual report to confirm dilution impact.
- Confirm the valuation of the underwriting fees settled (287,500 shares x AUD 4.80) against the original placement agreement terms.
- Review the status of the unquoted performance rights and options to assess potential future dilution.
- Check the original Appendix 3B announcement from October 24, 2025, for full details of the institutional placement terms.